DE.MEM LIMITED — Capital/Financing Update 2019

Nov 24, 2019

ASX RELEASE | De.mem Limited (ASX:DEM)

==> picture [567 x 87] intentionally omitted <==

De.mem Signs $1.7 Million Build, Own, Operate Contract

25 November 2019: Australian-Singaporean water and waste water treatment company De.mem (ASX:DEM) (“De.mem” or “the Company”) is pleased to announce that it has signed a Build, Own, Operate Contract (“BOO Contract”) in Singapore with a minimum value of A$1.7 million of revenue payable to the Company.

Under the BOO Contract, De.mem will operate a containerized waste water treatment system on-site at the customer’s factory in Singapore. De.mem’s system will treat the waste water generated by the customer’s production process to legal discharge standards, so that the treated waste water is safe to discharge into the public sewerage system.

The system will deploy numerous waste water treatment processes. In particular, De.mem’s innovative membrane technology is a key treatment step to achieve the desired treatment result. It will also use the Company’s waste water treatment chemicals as part of the treatment process.

The customer is Givaudan, the global leader in the creation of flavours and fragrances with sales of CHF 5.5 billion (AUD $8.1 billion) in 2018. Headquartered in Switzerland with local presence in almost 150 locations, it has more than 13,500 employees worldwide. The new BOO Contract is the second major project for De.mem with the same customer.

Commentary

De.mem CEO Andreas Kroell said: “The new contract highlights De.mem’s unique capability to offer Build, Own, Operate solutions to industrial clients.

Our BOO model offers clients a hassle-free, convenient service. Correspondingly, it provides stable, recurring and long-term revenue streams to De.mem.

De.mem’s BOO and service offering is based on our innovative membrane technology, which gives us a key competitive advantage. It is backed by our capability to operate & service integrated water and waste water treatment plants and the extended range of equipment, consumables and chemicals supplied, also as a result of the recent acquisition of German waste water treatment chemicals supplier Geutec Industrie- und Abwassertechnik GmbH.

Given our existing cash reserves, strong institutional shareholder base and potential debt finance solutions, we are increasingly able to offer more BOO solutions to corporate clients over extended periods of time. We see strong interest in this particular service offering from our customer base and look forward to building it further in the near-term.“

-ENDS-

==> picture [612 x 61] intentionally omitted <==

==> picture [567 x 87] intentionally omitted <==

For further information, please contact:

	De.mem Limited		Investor Enquires
	Andreas Kroell		George Gabriel, CFA
	CEO		Managing Director
	De.mem Limited		BLETCHLEY Park Capital
	investor@demem.com.sg		+61 3 8686 9144
			investors@bletchleyparkcapital.com.au

De.mem Limited (ASX:DEM) is a decentralised water and wastewater treatment business that designs, builds, owns and operates turnkey water and wastewater treatment systems for some of the world’s largest companies in the mining, electronics, chemical, oil & gas, and food & beverage industries. Its systems also provide municipalities, residential developments and hotels/resorts across the Asia Pacific with a reliable supply of clean drinking water.

De.mem’s technology to treat water and wastewater is among the most advanced globally. The Company is headquartered in Australia and has international locations in Singapore, Germany and Vietnam. It is commercialising an array of innovative proprietary technologies from its research and development partner, Nanyang Technological University (NTU) in Singapore, a world leader in membrane and water research. Technologies uniquely offered by De.mem include a revolutionary lowpressure hollow fibre nanofiltration membrane that uses less electricity and is cheaper to operate than conventional systems, as well as a new Forward Osmosis membrane deployed in de-watering applications or the concentration of liquids. To learn more, please visit: www.demembranes.com

Forward Looking Statements

Statements contained in this release, particularly those regarding possible or assumed future performance, revenue, costs, dividends, production levels or rates, prices or potential growth of De.mem Limited, are, or may be, forward looking statements. Such statements relate to future events and expectations and, as such, involve known and unknown risks and uncertainties. Actual results and developments may differ materially from those expressed or implied by these forwardlooking statements depending on a variety of factors.

==> picture [612 x 61] intentionally omitted <==